Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

PolarityTE, Inc. (PTE)

0.83   0.04 (5.02%) 01-27 15:57
Open: 0.8055 Pre. Close: 0.7903
High: 0.84 Low: 0.8027
Volume: 124,336 Market Cap: 6(M)

Technical analysis

as of: 2023-01-27 4:47:17 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.03     One year: 1.21
Support: Support1: 0.72    Support2: 0.62
Resistance: Resistance1: 0.88    Resistance2: 1.03
Pivot: 0.76
Moving Average: MA(5): 0.79     MA(20): 0.74
MA(100): 0.75     MA(250): 3.01
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 87.3     %D(3): 84.5
RSI: RSI(14): 64.1
52-week: High: 13  Low: 0.61
Average Vol(K): 3-Month: 198 (K)  10-Days: 46 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ PTE ] has closed below upper band by 3.2%. Bollinger Bands are 31.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.84 - 0.84 0.84 - 0.85
Low: 0.8 - 0.8 0.8 - 0.8
Close: 0.82 - 0.83 0.83 - 0.83

Company Description

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Headline News

Sat, 28 Jan 2023
Frasers Property Group toAcquire 50% Interest in NEX Suburban Retail Mall in Sinagpore - Sovereign Wealth Fund Institute

Sat, 28 Jan 2023
British soldier accused of terror offences appears in court - BBC

Fri, 27 Jan 2023
FengHe Fund Management Pte. Lt - GuruFocus.com

Thu, 26 Jan 2023
Pte Seán Rooney a 'genuine' man who will never be forgotten - Irish Examiner

Thu, 26 Jan 2023
Sports Titan Pte Ltd is Partnering Up with HokuApps to Re-Engineer ... - ACROFAN USA

Thu, 26 Jan 2023
Rivian Automotive, Inc. receives a $4.84 million investment from ... - Best Stocks

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 7 (M)
% Held by Insiders 6.1e+006 (%)
% Held by Institutions 16.3 (%)
Shares Short 761 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -2.771e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 592.4
Return on Equity (ttm) -58.3
Qtrly Rev. Growth 1.86e+006
Gross Profit (p.s.) 0
Sales Per Share -63.26
EBITDA (p.s.) 4.46491e+006
Qtrly Earnings Growth -6.4
Operating Cash Flow 0 (M)
Levered Free Cash Flow -26 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 0.39

Stock Dividends

Dividend 0
Forward Dividend 209680
Dividend Yield 0%
Dividend Pay Date 2016-07-31
Ex-Dividend Date 2016-01-11
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.